Exploring options for maintaining your weight after treatment with semaglutide? Take part in the PRESERVE study!

You may be eligible if you:

• Are between 18 and 75 years old
• Currently taking semaglutide for weight management
• Have been on the same dose of semaglutide for at least 3 months
• Have a BMI of at least 27 kg/m2

There are other requirements to participate.

This clinical research study aims to find out whether the investigational study drug ALV-100 maintains weight loss after stopping semaglutide. The study drug is designed to be taken monthly. Participants will receive diet and exercise counseling throughout the study period and will be compensated for study visits.

To learn more about PRESERVE, and whether it may be right for you, please contact:

Shruti - This email address is being protected from spambots. You need JavaScript enabled to view it. or 205-934-4980

or

Addy - This email address is being protected from spambots. You need JavaScript enabled to view it. or 205-934-3392